Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its boronic acid functionality enables participation in Suzuki-Miyaura cross-coupling reactions, making it valuable in medicinal chemistry for constructing carbon-carbon bonds. The cyclopropylaminocarbonyl group enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in research settings for designing enzyme inhibitors, especially in oncology and antiviral therapies.